ARGX

argenx SE

Price

$1,053.46

return (12m)

45.91%

p/e

3.11

p/bv

3.48

DIVIDEND YIELD

0.00%

ARGX price

argenx

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ARGX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

21.69%

3 months

18.19%

1 year

45.91%

2 years

99.74%

5 years

209.41%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ARGX

Valuation

P/E

3.11

Sector -4.23

Industry -4.23

P/BV

3.48

Sector 2.11

Industry 2.11

P/Revenue (PSR)

1.38

Sector 2.05

Industry 2.05

EV/EBITDA

24,369,853,570.23

Sector -546.75

Industry -546.75

EV/EBIT

Sector -37.85

Industry -37.85

P/EBITDA

6.59

Sector -51.33

Industry -51.33

P/EBIT

6.59

Sector -39.56

Industry -39.56

P/Total Assets

2.92

Sector 1.25

Industry 1.25

P/Net Current Assets

14.53

Sector -5.36

Industry -5.36

P/Working Capital

10.03

Sector -1.24

Industry -1.24

EPS

325.53

Sector -1.92

Industry -1.92

BVPS

290.18

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

96.17%

Sector 39.10%

Industry 39.10%

EBITDA Margin

0.00%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

0.00%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

30.58%

Sector -36.62%

Industry -36.62%

Net Profit Margins

44.41%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.15

Sector 0.03

Industry 0.03

Profitability

ROE

112.18%

Sector -60.49%

Industry -60.49%

ROA

94.12%

Sector -63.06%

Industry -63.06%

ROIC

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

5.12

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-5,232,453,884.57

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

-0.62

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.84

Sector 0.43

Industry 0.43

Liabilities/Assets

0.16

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

93.07%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ARGX

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF argenx ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$1,053.46

Fair Value

$1,457.88

Upside Return potential.

38.39%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ARGX argenx SE	$1,053.46	49.13%	0.00%	3.11	3.48	112.18%	44.41%
JNJ Johnson & Johnson	$278.43	61.14%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.81	24.40%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.21	26.74%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.51	-11.15%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$152.34	85.17%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.77	3.19%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$68.09	50.43%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$76.29	-49.14%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$444.12	60.34%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$843.47	49.29%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.76	51.02%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$921.38	33.91%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.96	39.14%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$248.61	68.36%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$41.86	12.83%	0.00%	12.57	2.28	18.14%	18.89%
BIIB Biogen Inc.	$224.51	60.79%	0.00%	38.52	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ARGX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT argenx

argenx SE

Average Investor10 user rating

4.0 (17 people)

United States

18 years

Founded: 2008

2017

Time since IPO - 9 years

336

Employees

argenx SE (United States) is listed on the Nasdaq and has a market capitalization of $65.13 billion, with shareholders equity totaling $18.69 billion.

The company employs approximately 336 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, argenx SE reported $47.22 billion in revenue, generating net income of $20.97 billion.

Key financial metrics include a P/E ratio of 3.11, a price-to-book (P/B) ratio of 3.48, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARGX.

Market cap

$65.13 billion

Net worth

$18.69 billion

$18,690,478,700.01

Assets

$22.28 billion

$22,276,687,931.38

Total Shares Outstanding

64.41 million

64,409,000

Average Daily Trading Volume

$778.46 Thousand

$778,458.32

Sector

Health Care

Industry

Biotechnology

ARGX

ARGX revenue and profits

Financial Results ARGX

DRAG THE FRAME TO SEE MORE DATA

ARGX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$921.38 33,94% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$248.61 68,60% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$278.43 60,45% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.21 26,06% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$152.34 88,32% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.77 3,29% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.81 25,67% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$921.38 33,94% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$248.61 68,60% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$278.43 60,45% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.21 26,06% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$152.34 88,32% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.77 3,29% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.81 25,67% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of argenx (ARGX) today?

A cotação de argenx (ARGX) hoje está em US$ 1,053.46, com uma variação de 45.91% em relação ao último ano. A cotação de argenx (ARGX) iniciou o ano negociando na casa dos US$ 840.95 e hoje está em US$ 1,053.46. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de argenx (ARGX) e dados de ações do Ibovespa e mercados internacionais.

Quando argenx (ARGX) paga dividendos?

argenx (ARGX) não distribuiu dividendos no último ano.

Is argenx (ARGX) a good investment?

Atualmente, argenx (ARGX) está cotada a US$ 1,053.46, com um P/L de 3.11, representando um desvio de -1,467% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 45.91 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 45.91%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy argenx (ARGX) stock?

Investir em ações de argenx (ARGX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of argenx (ARGX) yield today?

A rentabilidade de argenx (ARGX) foi de 21.69% no último mês, 45.91% no último ano e 209.41% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de argenx (ARGX) hoje, o investimento total seria de US$ 105,346.00, com base na cotação atual de US$ 1,053.46.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 153,710.35
Em 5 anos: US$ 325,951.06
Em 10 anos: US$ 105,346.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ARGX

argenx SE

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ARGX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING ARGX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT argenx

argenx SE

United States

18 years

2017

336

PROFIT X PRICE ARGX

Financial Results ARGX

ARGX cash flow

Asset, Revenue and Profit Growth - ARGX

ARGX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions